| Product ID | 70010-044_a2d6a7af-0570-064b-e053-2a95a90a0a83 |
| NDC | 70010-044 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Butalbita,Acetaminophen and Caffeine |
| Generic Name | Butalbita,acetaminophen And Caffeine |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-04-20 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA213321 |
| Labeler Name | Granules Pharmaceuticals Inc. |
| Substance Name | BUTALBITAL; ACETAMINOPHEN; CAFFEINE |
| Active Ingredient Strength | 50 mg/1; mg/1; mg/1 |
| Pharm Classes | Barbiturates [CS],Barbiturate [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |